related documents
- 412 BMS-754807, an oral dual IGF-1R/insulin receptor (IR) inhibitor: initial results from a Phase 1 dose- and schedule-finding study in combination with carboplatin/paclitaxel in subjects with solid tumors Conferences
- 491 NCIC CTG IND.177: Phase I study of AT7519M given as a short infusion twice weekly Conferences
- 58 Development and characterization of novel orally available Hypoxiainducible factor (HIF) signaling inhibitors as dual-mechanism cancer therapeutics Conferences